Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 03 Dec 2025 for Crinetics Pharmaceuticals, Inc., €73k. Read the official filing
Filing timeline
BuySaleDana Pizzuti
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Dana Pizzuti: trading record in brief
Dana Pizzuti is a declared insider of Crinetics Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 10 October 2022 and 1 December 2025, the trades on record add up to 22 filings.
On the market, this insider has only sold: 2 sales, €237k in total. Besides market trades, the filings include 6 share grants and 14 option exercises. Since January 2025: no purchases and 2 sales on the market.
The latest filing, published on 3 December 2025, reports an option exercise of €73k in Crinetics Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Dana Pizzuti
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
5,000 shares@ US$16.890.0016% mcap25.1% of flowCommon StockSEC:0001628280-25-055054:0
5,000 shares@ US$16.892.8% of flowCommon StockSEC:0001628280-25-049671:0
5,000 shares@ US$16.890.0016% mcap24.9% of flowCommon StockSEC:0001658247-25-000013:0
5,000 shares@ US$16.892.8% of flowCommon StockSEC:0001948238-25-000009:0
30,000 shares@ US$16.8917.6% of flowCommon StockSEC:0001948238-25-000007:0
6,492 shares@ US$29.187.9% of flowCommon StockSEC:0001948238-25-000005:0
2,388 shares@ US$34.173.7% of flowCommon StockSEC:0000950170-25-043407:0
43,000 shares0Common StockSEC:0000950170-25-025665:0
5,000 shares@ US$16.894.1% of flowCommon StockSEC:0000950170-25-014557:0
15,000 shares@ US$16.8912.1% of flowCommon StockSEC:0000950170-25-002869:0
14,375 shares@ US$16.8910.8% of flowCommon StockSEC:0000950170-24-113082:0
14,375 shares@ US$16.8911.1% of flowCommon StockSEC:0000950170-24-081878:0
9,500 shares@ US$16.897.4% of flowCommon StockSEC:0000950170-24-077402:0
14,375 shares@ US$16.8911.2% of flowCommon StockSEC:0000950170-24-045142:0
4,375 shares@ US$16.893.3% of flowCommon StockSEC:0001209191-24-005061:0
411 shares@ US$38.140.7% of flowCommon StockSEC:0001209191-24-005013:0
23,000 shares0Common StockSEC:0001209191-24-004607:0
14,375 shares@ US$16.8910.9% of flowCommon StockSEC:0001209191-24-000816:0
9,583 shares@ US$16.897.3% of flowCommon StockSEC:0001209191-23-059628:0
4,288 shares@ US$15.983.1% of flowCommon StockSEC:0001209191-23-023469:0
4,500 shares0Common StockSEC:0001209191-23-015609:0
12,500 shares0Common StockSEC:0001209191-22-053313:0
22 of 22 declarations
